3billion Alternatives & Competitors
12 companies similar to 3billion — Your One Answer Genetic testing for rare diseases made more efficient and more...
Companies similar to 3billion
CENTOGENE
Empowering precision medicine through advanced diagnosis
Rostock, Germany
Brazil
Congenica
Driving Precision Medicine
Cambridge, United Kingdom
Macrogen Europe
Committed to Sequencing Excellence
Amsterdam, The Netherland...
Rival Readout
Competing with 3billion? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Fabric Genomics
AI‑Driven Clinical Insights for Genomic Data
Oakland, United States
Australia
OncoDNA
Genomic and theranostic company specializing in precision medicine for the treatment of ca...
Belgium
IntegraGen
Company specializing in the genomics of cancer and genetic diseases
Evry, France
Malaysian Genomics Resource Centre Berhad
Genomics and biopharmaceutical company providing improved access to the latest immunothera...
Petaling Jaya, Malaysia
Clear Labs
Provider of fully automated next generation sequencing platforms, software and robotics fo...
San Carlos, United States
Beijing, China
Dhiti Omics
Precision Molecular Diagnostics & Genetic Testing
Bengaluru, India
About 3billion
3billion, founded in 2016, is revolutionizing the realm of genetic testing for rare diseases by leveraging AI-powered genomics. Headquartered in South Korea, this company is on a mission to make rare disease diagnosis faster, more accurate, and accessible on a global scale. With over 80,000 patients tested in collabora...
Diagnostic Gene Testing, Boosted Exome Analysis, Genome Sequencing, AI Variant Prioritization, Genomic Screenings (3B-NEO), Daily Data Updates, Gene Coverage Browser
Patients with Rare Diseases, Healthcare Providers, Medical Geneticists, Diagnostic Laboratories, Pharmaceutical Partners
AI-powered Genomics, Rare Disease Diagnostics, Genetic Testing, Bioinformatics, Genome Interpretation, WGS (Whole Genome Sequencing), WES (Whole Exome Sequencing), Diagnostic Reanalysis, Medical Collaboration, Genetic Services, Genomics Innovation, Healthcare Accessibility
B2B, SaaS, B2B2C
Product Sales, Tiered Pricing, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around 3billion: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at 3billion on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
